GlassScriptPhysician profile
Conrado E Talampas
NPI 1447204714
$4,232.75
in general payments reported to CMS, 2019-2025
33 companies · $705 in 2025
The $705 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $619 · 2021: $834 · 2022: $488 · 2023: $757 · 2024: $711 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,153 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,153.06 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $639.93 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $472.28 | 2019-2025 | Otezla, Repatha, Otezla |
| Pfizer INC. | $392.86 | 2019-2025 | |
| Lilly USA, LLC | $375.66 | 2020-2025 | Mounjaro, Jardiance, Kisunla |
| Novo Nordisk INC | $362.78 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $338.15 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $213.70 | 2023-2024 | Gemtesa |
| Amarin Pharma, INC. | $120.87 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $105.71 | 2020-2022 | |
| Boston Scientific Corporation | $99.40 | 2023-2024 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.43 | 2020-2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.53 | 2024-2025 | Xifaxan, Trulance |
| Abbvie INC. | $82.94 | 2021-2025 | |
| Glaxosmithkline, LLC. | $80.22 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $77.69 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $76.36 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Antares Pharma, INC. | $69.33 | 2021-2023 | Tlando, Xyosted, Nocdurna |
| Merck Sharp & Dohme LLC | $67.87 | 2019-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Abbott Laboratories | $61.24 | 2020-2025 | Freestyle Libre |
| Allergan, INC. | $57.64 | 2020 | |
| Eisai INC. | $51.10 | 2021-2025 | |
| Hikma Pharmaceuticals USA | $49.13 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.30 | 2021 | |
| Sanofi-Aventis U.S. LLC | $33.81 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $32.34 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.77 | 2022 | |
| Acadia Pharmaceuticals INC | $24.83 | 2024 | Nuplazid |
| Radius Health, INC. | $20.88 | 2021 | |
| Biogen, INC. | $20.08 | 2021 | |
| Eyevance Pharmaceuticals LLC | $19.32 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.32 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.64 | 2021 | |
| Corium, LLC | $8.64 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conrado Talampas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.